KCNN4 and neoplasm: We have demonstrated that KCa3.1 inhibition by shRNA or by pharmacological tools significantly reduced the tumor-infiltrated cerebral area, and also decreased astrogliosis and M/Mφ activation at the boundary of the tumor, suppressing M/Mφ phagocytosis and migration [116].